Syncona Partners

Venture Capital

Syncona is a leading FTSE 250 healthcare company and life science investor creating and scaling global leaders in life sciences.

London, United Kingdom · 10+ investments · 7 portfolio companies

Early Stage
Growth
Biotech
Healthcare
Life Sciences
Headquarters
London, United Kingdom
Founded
2012
Portfolio Companies
7
Total Investments
10
Last Investment
Oct 2024
Geographic Focus
Global

Investment Thesis

Maximise shareholder value and transform patient outcomes through life science investments.

Syncona Partners is a Venture Capital firm based in London, United Kingdom. It has made 10 investments, including Neogene Therapeutics, Autolus Therapeutics plc and Purespring. Focus areas include Biotech and Healthcare.

Portfolio7

Co-investors24

Sign up to view co-investors

24 co-investors across 28 shared portfolio companies — who they back alongside, and how often they lead.

Venture Capital ×14 · Private Equity ×4 · Corporate VC ×3 · 23 shared rounds

Investment History

Sign up to view investment history

Create a free account with 25 free credits every month, no card needed, to unlock deal history, amounts, and round details.

Your firm? Embed this profile

Add the live badge to your site — it stays current as your portfolio data updates.

Syncona Partners on Indexed.vc
<a href="https://indexed.vc/investors/syncona-partners"><img src="https://indexed.vc/api/badge/investor/syncona-partners" alt="Syncona Partners on Indexed.vc" width="260" height="76" /></a>